Behandlingen bør udelukkende foretages af speciallæger med særlig indsigt i immunosuppressiv behandling af organtransplanterede patienter.
The medicinal product should only be prescribed, and changes in immunosuppressive therapy initiated, by physicians experienced in immunosuppressive therapy and the management of transplant patients.